×
Siga Technologies Inventory 2010-2024 | SIGA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Siga Technologies inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
View More
Siga Technologies Inventory 2010-2024 | SIGA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Siga Technologies inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
Related Stocks
Company Name
Market
Cap
Zoetis (ZTS)
$89B
Takeda Pharmaceutical (TAK)
$47.2B
Merck (MKGAF)
$23.7B
Astellas Pharma (ALPMY)
$22.1B
Summit Therapeutics (SMMT)
$17.8B
Sandoz Group AG (SDZNY)
$17.6B
United Therapeutics (UTHR)
$15.2B
Shionogi (SGIOY)
$13.1B
Neurocrine Biosciences (NBIX)
$12.1B
Catalent (CTLT)
$10.9B
Orion OYJ (ORINY)
$7.4B
Revolution Medicines (RVMD)
$7.4B
Jazz Pharmaceuticals (JAZZ)
$6.8B
Ionis Pharmaceuticals (IONS)
$6.2B
Hikma Pharmaceuticals Plc (HKMPF)
$5.7B
Madrigal Pharmaceuticals (MDGL)
$5.1B
Corcept Therapeutics (CORT)
$4.4B
Crinetics Pharmaceuticals (CRNX)
$4.2B
Dyne Therapeutics (DYN)
$3.4B
PTC Therapeutics (PTCT)
$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.7B
Arrowhead Pharmaceuticals (ARWR)
$2.6B
Catalyst Pharmaceuticals (CPRX)
$2.4B
Soleno Therapeutics (SLNO)
$2.1B
Recursion Pharmaceuticals (RXRX)
$1.9B
Centessa Pharmaceuticals (CNTA)
$1.8B
BioCryst Pharmaceuticals (BCRX)
$1.6B
Xencor (XNCR)
$1.6B
Harrow (HROW)
$1.6B
Cassava Sciences (SAVA)
$1.5B